    	<div class="content_wrapper">
        	
        		<h1>About Emily</h1>
                <h2 style="margin-left:0">EMILY(Levonorgestrel releasing Intrauterine System)</h2>
	  			
                <p><strong>BRIEF PRESCRIBING INFORMATION</strong></p>
                    <p style="margin:0 0 5px">This information does not include all details needed to use Emily safely and effectively. See full prescribing information for Emily.</p>
                    <p style="margin:0 0 5px">Emily (Levonorgestrel releasing Intrauterine System)</p>
                    <p style="margin:0 0 5px">Approval date (India): 2011</p>

                <p><strong>INDICATIONS</strong></p>
                    <p>Emily is a sterile, Levonorgestrel releasing Intrauterine System indicated for: </p>
                    <ul>
                        <li>Intrauterine contraception for up to 3 years, in women who have at least one child.</li>
                        <li>Treatment of heavy menstrual bleeding for women who suffer from dysfunctional uterine bleeding and who are willing to accept LNG IUD as an alternative to hysterectomy or oral medications.</li>
                    </ul>
           
                <p><strong>DOSAGE AND ADMINISTRATION</strong></p>
                    <ul>
                        <li>Release rate of Levonorgestrel is approximately 20 Âµg per day; Emily should be replaced after 3 years. </li>
                        <li>To be inserted by a trained healthcare provider using strict aseptic technique. Healthcare providers are advised to become thoroughly familiar with the insertion instructions before attempting insertion.</li>
                        <li>Patient should be re-examined and monitored 4 to 12 weeks after insertion; then, yearly or more often if indicated. </li>
                    </ul>

                <p><strong>DOSAGE FORMS AND STRENGTHS</strong></p>
                    <p>One sterile Intrauterine System consisting of M-shaped polyethylene frame with a steroid reservoir containing 52 mg Levonorgestrel held within an inserter tube.</p>
					
					

                <p><strong>WARNINGS AND PRECAUTIONS</strong></p>
                    <ul>
                        <li>If pregnancy occurs with Emily in place, remove Emily. </li>
                        <li>Increased risk of ectopic pregnancy</li>
                        <li>Group A streptococcal infection has been reported; strict aseptic technique is essential during insertion. </li>
                        <li>Before using Emily, consider the risks of PID. </li>
                        <li>Bleeding patterns become altered, may remain irregular and amenorrhea may ensue. </li>
                        <li>Perforation may occur during insertion. Risk is increased in women with fixed retroverted uteri, during lactation, and postpartum. </li>
                        <li>Embedment in the myometrium and partial or complete expulsion may occur. </li>
                        <li>Persistent enlarged ovarian follicles should be evaluated</li>
                    </ul>

                <p><strong>ADVERSE REACTIONS</strong></p>
                    <p>The most common adverse reactions reported in clinical trials with a similar device (> 10%users) are uterine/vaginal bleeding alterations (51.9%), amenorrhea (23.9%), intermenstrual bleeding and spotting (23.4%), abdominal/pelvic pain (12.8%) and ovarian cysts (12%). </p>

                <p><strong>DRUG INTERACTIONS</strong></p>
                   <ul>
                        <li>Drugs or herbal products that induce certain enzymes, such as CYP3A4 may decrease the serum concentration of progestins.</li>
                    </ul>

                <p><strong>USE IN SPECIFIC POPULATIONS</strong></p>
                    <ul>
                        <li>Small amounts of progestins pass into breast milk resulting in detectable Steroid levels in infant serum. </li>
                        <li>Use of this product before menarche is not indicated. </li>
                        <li>Use in women over 65 has not been studied and is not approved. </li>
                    </ul>

<p><a href="<?php echo base_url();?>images/About_emily.pdf" target="_blank"><img src="<?php echo base_url();?>images/emilypdfbn.jpg"></a></p>




            <!-- End of Side Bar -->
	</div>
 